Coronary Artery Disease
Conditions
Keywords
Inconclusive Noninvasive Cardiac Stress Test, Cardiac Computed Tomography, Coronary Artery Disease, Atherosclerosis
Brief summary
Background: * Noninvasive cardiac stress testing is imperfect. Inconclusive test results generate further expensive testing. * In patients with known or suspected coronary artery disease, both computed tomography (CT) and magnetic resonance imaging (MRI) have been shown to provide suitable results for detecting the disease. However, both types of scans have limitations in their usefulness, and it is not known whether one is preferable in either accuracy or cost-effectiveness. Objectives: \- To determine the accuracy and cost-effectiveness of CT and MRI in subjects with a prior inconclusive heart stress test. Eligibility: \- Patients 18 years of age and older who have had an inconclusive heart stress test within the past 90 days. Design: * A blood test will be obtained prior to both heart tests. This will require less than a teaspoon of blood. * A CT scan will be performed, accompanied by beta blocker medications (to slow heart rate) or nitroglycerin (to enlarge blood vessels) to improve picture quality, as needed. * An MRI scan will be performed. Scans will be taken before, during, and after the patient receives vasodilators (to increase blood flow to the coronary arteries and detect blockages in heart blood vessels). * Heart rate and function will be monitored with an electrocardiogram.
Detailed description
Noninvasive cardiac stress testing is imperfect. Inconclusive test results generate further expensive testing. We will do both cardiac computed tomography (CT) and stress cardiac magnetic resonance imaging (MRI) in patients who have an inconclusive noninvasive cardiac stress test. We will test whether MRI predicts significant coronary artery disease in a more cost-effective and accurate manner than CT, or vice versa.
Interventions
None listed
Sponsors
National Heart, Lung, and Blood Institute (NHLBI)
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No
Inclusion criteria
* GENERAL INCLUSION CRITERIA: * 18 years of age and older * Prior equivocal stress study within the preceding 90 days * Able to provide informed consent MEDICAL
Exclusion criteria
* Decompensated heart failure (unable to lie flat during MRI or CT) * Severe kidney disease (MDRD estimated Glomerular Filtration Rate less than 30mL/min/1.73m(2). * Prior cardiac revascularization with coronary stent or bypass surgery * Resting tachycardia (HR greater than l00 bpm) * Pregnant women (when uncertain, subjects will undergo urine or blood testing) * Lactating women (unless they are willing to discard breast milk for 24 hours after receiving gadolinium) * Second (Type II) and third degree atrioventricular heart block * Asthma or chronic pulmonary disease (emphysema) actively treated with bronchodilators or leukotriene antagonists MRI
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Stress MRI perfusion, and cardiac CT will have observed sensitivity, specificity, and accuracy of at least 0.80 in predicting CAD in a patient population with prior equivocal stress testing. | end of study | estimate the sensitivity, specificity, and accuracy of MRI and CT, for detecting obstructive CAD in patients with a prior equivocal stress study |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The null hypothesis is that there will be no difference between stress MRI perfusion and cardiac CT with respect to the diagnostic costs for patients with an equivocal stress study for CAD. | end of study | compare the cost-effectiveness of MRI with CT for this patient population. |
Countries
United States
Outcome results
None listed